The purpose of this study is to evaluate cognition in smokers and nonsmokers. It involves
administration of intranasal insulin (Novolin R), an investigational medication followed by a
brief non-invasive cognitive test. All participants will receive both Novolin R and placebo
in two separate testing sessions.